ALS patient’s brain-computer interface success exposes systemic gaps in neurotechnology access and care equity
Original framing: “This man with ALS is “the first power user” of a brain implant that lets him speak” — MIT Technology Review
If BCIs become mainstream, they may exacerbate global health disparities, with wealthy nations and individuals monopolizing access while others rely on outdated care models. Scenario planning suggests that without regulatory reforms, BCIs could become another 'digital divide'—where the rich gain cognitive enhancements while the poor are left with palliative care. Ethical frameworks must prioritize equitable distribution, long-term safety monitoring, and patient autonomy over commercialization.
Casey Harrell’s story is a microcosm of how neurotechnology innovation is shaped by colonial legacies, capitalist extraction, and Western-centric definitions of progress.
The celebration of his BCI success obscures the fact that most ALS patients—particularly in the Global South or marginalized communities—will never access such interventions due to structural barriers like cost, lack of clinical trials in their regions, or insurance denials. Historically, medical breakthroughs have often served as PR for institutions while systemic inequities persist, and Harrell’s case is no exception: his access to a cutting-edge BCI at a top-tier research institution reflects the concentration of power in elite scientific hubs, not a scalable solution. Cross-culturally, alternative models of care—from Māori kinship networks to Bhutan’s Gross National Happiness framework—demonstrate that disability support does not require invasive technology to be meaningful. The real challenge is not whether BCIs work for a privileged few, but how to redesign global health systems to prioritize dignity, equity, and community-based care over Silicon Valley’s next 'disruptive' solution. Without this shift, Harrell’s story will remain an outlier rather than a blueprint for inclusive innovation.